Our goal is to reinvigorate the treatment landscape for difficult-to-target tumors with new foundational therapies. Our technology mimics the self-assembly of DNA to create unprecedentedly small nanomedicines, each containing a duo of anti-cancer therapies, that can extravasate deep within tumors. Unique conditions within the tumor microenvironment cleave the environmentally sensitive bonds of our nanomedicines, releasing therapy directly in the tumor - exactly where it needs to be.